EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

TPS45 - Dermatology 3

Saturday 01 Jun, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
A two-sample bidirectional Mendelian randomization study revealed atopic dermatitis is associated with an increased risk of migraine
Aquagenic urticaria successfully treated with UVB-311
Association between diet quality and atopic dermatitis: a cross-sectional analysis based on the 1999-2004 National Health and Nutrition Examination Survey
Clinical experience with newer systemic treatment for moderate to severe atopic dermatitis in children and adolescents: a single-centre study
Corticophobia among health care professionals
Corticosteroids in Atopic Dermatitis - A Love Hate Relationship?
Dermatological Dichotomy: A Case of Coexisting Atopic Dermatitis and Mycosis Fungoides
Effects of topical JAK inhibitor on skin inflammation and itching in FADS mouse
Efficacy and Safety of 1-Year Dupilumab Treatment in Children Aged 6-11 years with Moderate-to-Severe Atopic Dermatitis in South Korea: Multicenter Prospective Observational Study
First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma
Fixed drug eruption caused by lansoprazole
Genetic aspects among Brazilian patients with Atopic Dermatitis: are Filaggrin variants relevant in the pathogenesis of the disease?
Infant atopic dermatitis and maternal anxiety and depression: a mixed methods case-control study
Prevalence and impact of allergic comorbidities in patients with severe atopic dermatitis in treatment with Dupilumab
Systemic Treatment of Atopic Dermatitis in Pregnancy: The Physician’s Perspective

Speakers